Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: Case report and literature review

24Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background. Radiofrequency ablation (RFA) is a minimally invasive technique that can eradicate malignant disease in the liver, including metastatic disease from gynecological primary tumors. Case. An 81-year-old female underwent percutaneous RFA for a solitary intrahepatic metastatic lesion that was her only known site of disease 2 years after definitive surgery and chemotherapy for stage IIIC ovarian adenocarcinoma. She was able to start systemic chemotherapy 1 week after RFA, and continues to be free of disease in the liver. Conclusion. RFA can be a useful tool for treating liver tumors in patients who would otherwise not be candidates for liver resection. Its advantages include minimal invasiveness, low morbidity, and rapid recovery for expeditious treatment with systemic chemotherapy. © 2004 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Bojalian, M. O., Machado, G. R., Swensen, R., & Reeves, M. E. (2004). Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: Case report and literature review. Gynecologic Oncology, 93(2), 557–560. https://doi.org/10.1016/j.ygyno.2004.01.041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free